Screener
Rigel Pharmaceuticals RIGL Gross Profit
Gross Profit at other companies
Other financials
Where this comes from
Calculated from Rigel Pharmaceuticals’s reported figures.
The source filing: Rigel Pharmaceuticals’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 4:05 PM EDT
- Fiscal quarter
- Q4 FY2026
- Calendar quarter
- Q4 2026
- Accession
- 0001034842-26-000032
FAQ
- What is Rigel Pharmaceuticals's gross profit?
- Rigel Pharmaceuticals (RIGL) reported gross profit of $54.21M in Q1 2026.
- How has Rigel Pharmaceuticals's gross profit changed year-over-year?
- Rigel Pharmaceuticals's gross profit increased by 10.8% year-over-year, from $48.92M to $54.21M.
- What is the long-term trend for Rigel Pharmaceuticals's gross profit?
- Over 4 years (2021 to 2025), Rigel Pharmaceuticals's gross profit has grown at a 16.7% compound annual growth rate (CAGR), from $148.15M to $274.66M.
- What does gross profit mean?
- Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.
Ask your AI about Rigel Pharmaceuticals's gross profit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude